Infectious Conferences|Paris|France|2017 infectious.gavinconferences.com

Infectious Congress 2017


About Conference

Gavin Conferences invites participants from all over the world to attend “World Congress on Infectious & Rare Diseases” is a two-day conference scheduled during October 2-3, 2017 at Paris, France, and is open to attendees, academics and non-academic audiences.

The two-day conference is designed to bring researchers, scientists, academicians, doctorates, professors, lecturers, scholars and entrepreneurs to discuss research and share ideas regarding career interests to make event experience even better. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi. The diseases can be spread, directly or indirectly, from one person to another. During the event, participants can build networks and share information and ideas with one another to make them aware of the infectious diseases its spread, treatment and most probably eradication of the problems caused by it.

Aim

Our Aim is to illuminate the advances in the infectious diseases in preventing and eradicating modern day diseases with the special focus on the life threatened chronic and acute ailments

Market analysis

The global market for infectious disease diagnostic, vaccine, and treatment products reached $108.4 billion in 2015. The market should reach $126.2 billion in 2016 and $183.2 billion in 2021, demonstrating a compound annual growth rate (CAGR) of 7.7% from 2016 to 2021.


Conference Highlights

1.1Next generation sequencing
1.2 Listeriosis, Neisseria, Gonorrhea, and Meningitis
1.3 HIV/AIDS
1.4 Ebola
1.5 Tularemia
1.6 Zika
1.7 Salmonellosis and shigellosis
1.8 Sexually Transmitted Infections
1.9 Gastroenteritis, urinary tract infections, and neonatal meningitis
1.10 Multidrug-resistant tuberculosis (MDR-TB)
1.11 Anthrax
1.12 Zoonoses
1.13 Chikungunya
1.14 Smallpox
1.15 Tick-borne encephalitis virus
1.16 Crimean-Congo hemorrhagic fever virus
1.17 SARS coronavirus
1.18 Tick-borne hemorrhagic fever viruses
1.19 SARS and MERS
1.20 Dengue
1.21 Parvovirus
Alexander disease
Barth syndrome
Gaucher disease
Duchenne muscular dystrophy
Charcot-Marie-Tooth disease
Alkaptonuria
Krabbe leukodystrophy
Huntington disease
Fabry disease
Dravet syndrome
Ataxia-telangiectasia
Niemann-Pick disease
Joubert syndrome
Zellweger syndrome
Marfan syndrome
Hypophosphatasia
Progeria
Rare Infectious Diseases
Preconception and antenatal care
Development of Orphan medical products
Genetic studies
Carrier Testing
Polio
Pox Disease
Viral molecular epidemiology
Measles, Mumps, and Rubella
Virology
Smallpox
Hantavirus
Rotavirus
Marburg virus
Rabies
Viral hepatitis
Human Immunodeficiency virus / Acquired Immunodeficiency Syndrome
Hemorrhagic Fevers and Acute Viral Infections
Zoonotic viral diseases
Influenza
Respiratory viruses
Infectious Diseases in Africa
Infectious Diseases in Europe
Infectious Diseases in Asia
Infectious Diseases in North America
Infectious Diseases in South America
Orphan Drug Act
Current Legislation/Regulations
Clinical Development Challenges
Antiinflammatory drugs and NSAIDS
Antibiotics
Traditional medicines
Disinfecting with UV Technology
Chemotherapy
Infection Novel Therapies
Herbal treatment
Disinfectants
Anticancers
Antiseptics
Antibacterials
Antimalarials
Antivirals
Antituberculars
Antimicrobials
Antiparasitics
Recent outbreaks of infections from Contaminated pharmaceuticals
Pharmacopoeial limits
Microbial Contamination in Counterfeit Medications
Potential threats associated with Contaminated Pharmaceuticals
Microbial cultivable contaminations
Non-Typical of COPD
Emphysema
Oxidative Stress
Chronic Bronchitis
Asthma COPD Overlap Syndrome (ACOS)
Systemic Effects
Gonorrhea and Chlamydia
Human Papillomavirus (HPV)
Genital Herpes
Factors affecting morbidity
Bacterial Vaginosis
Viral Hepatitis
Trichomoniasis
Syphilis
HIV/AIDS
During Pregnancy
Pap test
HPV test
Blood test
Swab tests of blood urine & genitals
Physical examination
Urine test
Genital warts
Anal secretions-test
Educational programs
Clinical training
Safe sex
Screening Recommendations
Disinfection equipments
Municipal water treatment
Chemicals and bulk drugs
Laboratory testing tools
Nanomaterials
Molecular diagnostics
Drug formulation devices
Testing tools
Pharmaceuticals
Filter media
Devices and instruments
Environmental products
Drug device combinations

Supporting Journal

Infectious